China Pharma Holdings Inc (CPHI) Actualités

Form 8-K - Current report

Form 8-K - Current report

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville PR Newswire HAIKOU, China, Dec. 18...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

China Pharma Announces the Entry of "At-The-Market" Equity Offering

China Pharma Announces the Entry of "At-The-Market" Equity Offering PR Newswire HAIKOU, China, Dec. 13, 2024 HAIKOU, China, Dec. 13...

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 PR Newswire HAIKOU, China...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split PR Newswire HAIKOU, China, Feb. 23, 2024 HAIKOU, China, Feb. 23, 2024...